FABP5 and neoplasm: Binding sites of miR-22-3p on FABP5 predicted by PITA, miRmap and miRanda were shown in Fig. 4A. To test the accuracy of the miRNA-mRNA interactions predicted via ENCORI approach and ensure the innovation of the study, we chose LIHC cell lines for the validation of the potential miR-22-3p-FABP5 association that has not been reported in any tumor type yet.